Gene Symbol | Gene ID | Gene Info |
---|---|---|
OTX1
|
ENSG00000115507.5 | orthodenticle homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_63285064_63285215 | OTX1 | 7202 | 0.239393 | 0.81 | 7.7e-03 | Click! |
chr2_63284454_63284605 | OTX1 | 6592 | 0.242037 | 0.77 | 1.4e-02 | Click! |
chr2_63285363_63285918 | OTX1 | 7703 | 0.237606 | 0.75 | 2.0e-02 | Click! |
chr2_63286662_63286820 | OTX1 | 8804 | 0.234483 | 0.74 | 2.3e-02 | Click! |
chr2_63276937_63277124 | OTX1 | 162 | 0.937363 | 0.72 | 2.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_77578325_77578530 | 0.60 |
CYSLTR1 |
cysteinyl leukotriene receptor 1 |
4553 |
0.35 |
chr17_71589775_71590041 | 0.59 |
RP11-277J6.2 |
|
47257 |
0.14 |
chr3_16355269_16355595 | 0.54 |
RP11-415F23.2 |
|
514 |
0.77 |
chr19_30472030_30472181 | 0.53 |
URI1 |
URI1, prefoldin-like chaperone |
10105 |
0.31 |
chr4_109031503_109031852 | 0.52 |
LEF1 |
lymphoid enhancer-binding factor 1 |
55780 |
0.13 |
chr3_13388775_13388976 | 0.49 |
NUP210 |
nucleoporin 210kDa |
72934 |
0.11 |
chr8_128989307_128989493 | 0.48 |
ENSG00000221771 |
. |
16521 |
0.16 |
chr7_50426534_50426685 | 0.47 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
59364 |
0.13 |
chr18_29623121_29623509 | 0.47 |
ENSG00000265063 |
. |
17637 |
0.13 |
chr4_143619137_143619288 | 0.46 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
137390 |
0.05 |
chr3_69113784_69113935 | 0.46 |
TMF1 |
TATA element modulatory factor 1 |
12375 |
0.13 |
chrX_70321837_70321988 | 0.45 |
CXorf65 |
chromosome X open reading frame 65 |
4543 |
0.12 |
chr1_168490958_168491381 | 0.45 |
XCL2 |
chemokine (C motif) ligand 2 |
22066 |
0.23 |
chr3_73014643_73014836 | 0.45 |
GXYLT2 |
glucoside xylosyltransferase 2 |
10373 |
0.2 |
chr17_66235194_66235719 | 0.44 |
AMZ2 |
archaelysin family metallopeptidase 2 |
8259 |
0.16 |
chr17_62980411_62980628 | 0.44 |
AMZ2P1 |
archaelysin family metallopeptidase 2 pseudogene 1 |
10884 |
0.15 |
chr13_42967027_42967422 | 0.44 |
AKAP11 |
A kinase (PRKA) anchor protein 11 |
120935 |
0.06 |
chr11_35144638_35144937 | 0.44 |
AL356215.1 |
|
5428 |
0.19 |
chr18_45437859_45438131 | 0.44 |
SMAD2 |
SMAD family member 2 |
12018 |
0.24 |
chrX_135774515_135774666 | 0.43 |
CD40LG |
CD40 ligand |
44204 |
0.12 |
chr2_204596118_204596345 | 0.43 |
CD28 |
CD28 molecule |
24815 |
0.19 |
chr1_71545897_71546091 | 0.43 |
ZRANB2 |
zinc finger, RAN-binding domain containing 2 |
700 |
0.48 |
chr18_29639731_29640017 | 0.43 |
ENSG00000265063 |
. |
1078 |
0.43 |
chr19_36101325_36101624 | 0.43 |
HAUS5 |
HAUS augmin-like complex, subunit 5 |
2198 |
0.15 |
chr10_116258251_116258448 | 0.43 |
ABLIM1 |
actin binding LIM protein 1 |
10597 |
0.26 |
chr1_193447478_193447673 | 0.42 |
ENSG00000252241 |
. |
253499 |
0.02 |
chr9_21558528_21559235 | 0.42 |
MIR31HG |
MIR31 host gene (non-protein coding) |
787 |
0.64 |
chr2_68976425_68976789 | 0.42 |
ARHGAP25 |
Rho GTPase activating protein 25 |
14593 |
0.24 |
chr15_55514993_55515430 | 0.41 |
RSL24D1 |
ribosomal L24 domain containing 1 |
25946 |
0.18 |
chr17_20178582_20178828 | 0.41 |
ENSG00000252971 |
. |
14865 |
0.17 |
chr7_50300607_50300758 | 0.41 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
43642 |
0.18 |
chr14_106471839_106472077 | 0.41 |
IGHV1-3 |
immunoglobulin heavy variable 1-3 |
235 |
0.74 |
chr13_52527464_52527703 | 0.41 |
ATP7B |
ATPase, Cu++ transporting, beta polypeptide |
8468 |
0.22 |
chr6_157877638_157877932 | 0.40 |
ENSG00000266617 |
. |
72379 |
0.11 |
chr5_150517774_150517925 | 0.40 |
ANXA6 |
annexin A6 |
3352 |
0.26 |
chr3_59392779_59393077 | 0.40 |
C3orf67 |
chromosome 3 open reading frame 67 |
357118 |
0.01 |
chr21_43842200_43842523 | 0.40 |
ENSG00000252619 |
. |
4659 |
0.15 |
chr13_24840686_24840890 | 0.40 |
SPATA13 |
spermatogenesis associated 13 |
4038 |
0.2 |
chr1_161904536_161904981 | 0.40 |
OLFML2B |
olfactomedin-like 2B |
50264 |
0.14 |
chr12_68575483_68575644 | 0.40 |
IFNG |
interferon, gamma |
22036 |
0.21 |
chrX_49148626_49148900 | 0.39 |
GAGE10 |
G antigen 10 |
11385 |
0.08 |
chr6_15421901_15422177 | 0.39 |
JARID2 |
jumonji, AT rich interactive domain 2 |
20950 |
0.24 |
chr11_113944900_113945166 | 0.39 |
ENSG00000221112 |
. |
12618 |
0.2 |
chr6_112020418_112020739 | 0.39 |
FYN |
FYN oncogene related to SRC, FGR, YES |
20687 |
0.21 |
chr11_102175960_102176111 | 0.39 |
ENSG00000212466 |
. |
8418 |
0.18 |
chr1_92876308_92876612 | 0.39 |
ENSG00000242764 |
. |
8218 |
0.25 |
chr1_203297729_203297923 | 0.39 |
ENSG00000202300 |
. |
9599 |
0.17 |
chr20_34077500_34077678 | 0.38 |
RP3-477O4.14 |
|
1154 |
0.34 |
chr17_37956193_37956565 | 0.38 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
21901 |
0.13 |
chr9_98776919_98777112 | 0.37 |
ERCC6L2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6-like 2 |
41896 |
0.17 |
chr5_56126261_56126427 | 0.37 |
MAP3K1 |
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
14943 |
0.16 |
chr13_75870281_75870432 | 0.37 |
TBC1D4 |
TBC1 domain family, member 4 |
45311 |
0.17 |
chr1_65886839_65886990 | 0.37 |
LEPR |
leptin receptor |
511 |
0.52 |
chr14_67956006_67956206 | 0.37 |
TMEM229B |
transmembrane protein 229B |
657 |
0.69 |
chr11_73691666_73692195 | 0.37 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
53 |
0.97 |
chr9_5352223_5352380 | 0.37 |
RLN1 |
relaxin 1 |
12428 |
0.21 |
chr6_509432_509583 | 0.37 |
RP1-20B11.2 |
|
14664 |
0.28 |
chrX_44124831_44125014 | 0.37 |
EFHC2 |
EF-hand domain (C-terminal) containing 2 |
77996 |
0.11 |
chr5_156735418_156735569 | 0.36 |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
2552 |
0.24 |
chr19_41807163_41807314 | 0.36 |
CCDC97 |
coiled-coil domain containing 97 |
8856 |
0.11 |
chr11_78002899_78003070 | 0.36 |
RP11-452H21.1 |
|
32820 |
0.15 |
chr12_46364467_46364684 | 0.36 |
SCAF11 |
SR-related CTD-associated factor 11 |
19773 |
0.26 |
chr1_206913351_206913502 | 0.36 |
ENSG00000199349 |
. |
8011 |
0.16 |
chr12_15697618_15697769 | 0.36 |
PTPRO |
protein tyrosine phosphatase, receptor type, O |
1593 |
0.52 |
chr5_37112693_37112953 | 0.36 |
NIPBL |
Nipped-B homolog (Drosophila) |
53818 |
0.14 |
chr4_148973362_148973513 | 0.36 |
RP11-76G10.1 |
|
94185 |
0.09 |
chr6_42345837_42346043 | 0.36 |
ENSG00000221252 |
. |
34194 |
0.17 |
chr17_65438464_65438635 | 0.36 |
ENSG00000244610 |
. |
14857 |
0.13 |
chr9_92031645_92032185 | 0.36 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
1833 |
0.43 |
chr14_61968102_61968253 | 0.36 |
RP11-47I22.4 |
|
27669 |
0.17 |
chr3_98619464_98619615 | 0.35 |
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
476 |
0.75 |
chr11_67179855_67180006 | 0.35 |
CARNS1 |
carnosine synthase 1 |
3219 |
0.09 |
chrX_12970579_12970730 | 0.35 |
TMSB4X |
thymosin beta 4, X-linked |
22573 |
0.18 |
chr2_74258513_74258824 | 0.35 |
TET3 |
tet methylcytosine dioxygenase 3 |
14782 |
0.17 |
chr2_135437840_135437991 | 0.35 |
TMEM163 |
transmembrane protein 163 |
38655 |
0.21 |
chr15_45030741_45030930 | 0.35 |
TRIM69 |
tripartite motif containing 69 |
2071 |
0.27 |
chr15_87158408_87158697 | 0.35 |
RP11-182L7.1 |
|
15815 |
0.3 |
chr8_81990406_81990557 | 0.35 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
33822 |
0.22 |
chr8_66854346_66854497 | 0.35 |
DNAJC5B |
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
79374 |
0.1 |
chr5_169703034_169703822 | 0.35 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
9097 |
0.23 |
chr10_73869748_73870117 | 0.35 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
21142 |
0.19 |
chr3_150458439_150458615 | 0.35 |
SIAH2-AS1 |
SIAH2 antisense RNA 1 |
21197 |
0.14 |
chr5_75745118_75745695 | 0.35 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
45157 |
0.18 |
chr2_75438200_75438351 | 0.34 |
TACR1 |
tachykinin receptor 1 |
11449 |
0.25 |
chr2_191280417_191280683 | 0.34 |
MFSD6 |
major facilitator superfamily domain containing 6 |
7469 |
0.21 |
chr18_2639431_2639582 | 0.34 |
ENSG00000200875 |
. |
10360 |
0.14 |
chr6_111521255_111521563 | 0.34 |
SLC16A10 |
solute carrier family 16 (aromatic amino acid transporter), member 10 |
22994 |
0.17 |
chrX_25038113_25038264 | 0.34 |
ARX |
aristaless related homeobox |
4123 |
0.31 |
chr14_56614561_56614722 | 0.34 |
PELI2 |
pellino E3 ubiquitin protein ligase family member 2 |
28814 |
0.22 |
chr7_50440859_50441289 | 0.34 |
ENSG00000200815 |
. |
62004 |
0.12 |
chr8_144938668_144938819 | 0.34 |
ENSG00000264144 |
. |
12503 |
0.09 |
chr6_194026_194220 | 0.34 |
DUSP22 |
dual specificity phosphatase 22 |
97507 |
0.09 |
chr5_139792182_139792333 | 0.34 |
ANKHD1 |
ankyrin repeat and KH domain containing 1 |
10751 |
0.11 |
chr7_50362495_50362678 | 0.34 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
4659 |
0.32 |
chr3_108551517_108551700 | 0.34 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
9989 |
0.26 |
chr13_74860376_74860556 | 0.34 |
ENSG00000206617 |
. |
2885 |
0.39 |
chr21_16887561_16887770 | 0.33 |
ENSG00000212564 |
. |
98937 |
0.08 |
chr9_33026322_33026547 | 0.33 |
DNAJA1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
1161 |
0.45 |
chr5_140800694_140800866 | 0.33 |
PCDHGA11 |
protocadherin gamma subfamily A, 11 |
15 |
0.92 |
chr10_124300753_124301107 | 0.33 |
DMBT1 |
deleted in malignant brain tumors 1 |
19251 |
0.2 |
chr4_6174725_6175042 | 0.33 |
JAKMIP1 |
janus kinase and microtubule interacting protein 1 |
21461 |
0.25 |
chr19_5971655_5971871 | 0.33 |
RANBP3 |
RAN binding protein 3 |
6327 |
0.12 |
chr7_114645798_114646091 | 0.33 |
MDFIC |
MyoD family inhibitor domain containing |
72020 |
0.13 |
chr1_29245607_29245758 | 0.33 |
EPB41 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
4591 |
0.21 |
chr2_68379385_68379654 | 0.33 |
WDR92 |
WD repeat domain 92 |
5086 |
0.18 |
chr11_73702815_73702966 | 0.33 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
8538 |
0.14 |
chr12_54675160_54675465 | 0.33 |
HNRNPA1 |
heterogeneous nuclear ribonucleoprotein A1 |
342 |
0.7 |
chr1_100863756_100864116 | 0.33 |
ENSG00000216067 |
. |
19605 |
0.19 |
chr14_65395685_65395897 | 0.33 |
CHURC1-FNTB |
CHURC1-FNTB readthrough |
5037 |
0.12 |
chr5_85334298_85334449 | 0.33 |
NBPF22P |
neuroblastoma breakpoint family, member 22, pseudogene |
244211 |
0.02 |
chr15_45001470_45001621 | 0.33 |
B2M |
beta-2-microglobulin |
2130 |
0.24 |
chr7_12297969_12298124 | 0.33 |
TMEM106B |
transmembrane protein 106B |
47097 |
0.19 |
chr3_18470958_18471238 | 0.33 |
SATB1 |
SATB homeobox 1 |
4237 |
0.24 |
chr7_13950051_13950250 | 0.32 |
ETV1 |
ets variant 1 |
75916 |
0.12 |
chr3_33091306_33091488 | 0.32 |
GLB1 |
galactosidase, beta 1 |
46887 |
0.11 |
chr3_98277242_98277459 | 0.32 |
GPR15 |
G protein-coupled receptor 15 |
26607 |
0.12 |
chr10_1168832_1168983 | 0.32 |
WDR37 |
WD repeat domain 37 |
48584 |
0.12 |
chr2_191925730_191925888 | 0.32 |
ENSG00000231858 |
. |
39557 |
0.13 |
chr11_66393466_66393617 | 0.32 |
RBM14 |
RNA binding motif protein 14 |
9355 |
0.09 |
chr12_104896776_104896927 | 0.32 |
CHST11 |
carbohydrate (chondroitin 4) sulfotransferase 11 |
46072 |
0.17 |
chr21_43658115_43658266 | 0.32 |
ENSG00000223262 |
. |
16907 |
0.16 |
chr11_75219570_75220088 | 0.32 |
RP11-939C17.4 |
|
393 |
0.82 |
chr1_154912617_154913094 | 0.31 |
PMVK |
phosphomevalonate kinase |
3388 |
0.11 |
chr7_55584165_55584331 | 0.31 |
VOPP1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
478 |
0.86 |
chr16_18811637_18811837 | 0.31 |
ARL6IP1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
1009 |
0.33 |
chr15_38545893_38546208 | 0.31 |
SPRED1 |
sprouty-related, EVH1 domain containing 1 |
668 |
0.83 |
chrX_19786390_19786617 | 0.31 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
20682 |
0.27 |
chr7_35687826_35688061 | 0.31 |
HERPUD2 |
HERPUD family member 2 |
46233 |
0.16 |
chr15_75136605_75137116 | 0.31 |
ULK3 |
unc-51 like kinase 3 |
1322 |
0.29 |
chr10_112483545_112483823 | 0.31 |
ENSG00000252036 |
. |
32530 |
0.14 |
chr3_71437386_71437590 | 0.31 |
FOXP1 |
forkhead box P1 |
83577 |
0.1 |
chr17_33865226_33865568 | 0.31 |
SLFN12L |
schlafen family member 12-like |
517 |
0.66 |
chr5_156994069_156994363 | 0.31 |
AC106801.1 |
|
1244 |
0.41 |
chr1_192484853_192485075 | 0.31 |
ENSG00000221145 |
. |
24614 |
0.2 |
chrX_3605354_3605505 | 0.31 |
PRKX |
protein kinase, X-linked |
26220 |
0.16 |
chr3_195250615_195250766 | 0.31 |
ENSG00000252620 |
. |
671 |
0.67 |
chr20_57735088_57735478 | 0.31 |
ZNF831 |
zinc finger protein 831 |
30792 |
0.19 |
chr12_102453949_102454100 | 0.31 |
CCDC53 |
coiled-coil domain containing 53 |
1833 |
0.31 |
chr16_75661496_75661713 | 0.31 |
ADAT1 |
adenosine deaminase, tRNA-specific 1 |
4406 |
0.16 |
chr2_135080063_135080349 | 0.31 |
MGAT5 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase |
68376 |
0.13 |
chr7_140571114_140571265 | 0.31 |
ENSG00000271932 |
. |
12683 |
0.23 |
chr4_40305683_40306008 | 0.31 |
CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
31501 |
0.18 |
chr3_56769543_56769694 | 0.31 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
39977 |
0.18 |
chr15_60871500_60871746 | 0.31 |
RORA |
RAR-related orphan receptor A |
13117 |
0.21 |
chrX_119889254_119889658 | 0.31 |
CT47B1 |
cancer/testis antigen family 47, member B1 |
120323 |
0.04 |
chr2_216948536_216948711 | 0.30 |
TMEM169 |
transmembrane protein 169 |
1981 |
0.27 |
chr1_160592657_160592947 | 0.30 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
24009 |
0.13 |
chr16_3859769_3859931 | 0.30 |
CREBBP |
CREB binding protein |
28982 |
0.18 |
chr6_37467874_37468104 | 0.30 |
CCDC167 |
coiled-coil domain containing 167 |
291 |
0.92 |
chr8_66843360_66843705 | 0.30 |
PDE7A |
phosphodiesterase 7A |
89345 |
0.09 |
chr10_8102007_8102158 | 0.30 |
GATA3 |
GATA binding protein 3 |
5313 |
0.35 |
chr8_52810108_52810331 | 0.30 |
RP11-110G21.2 |
|
1285 |
0.3 |
chr13_48809086_48809237 | 0.30 |
ITM2B |
integral membrane protein 2B |
1822 |
0.45 |
chr4_40213832_40214143 | 0.30 |
RHOH |
ras homolog family member H |
12023 |
0.22 |
chr14_98871416_98871598 | 0.30 |
ENSG00000241757 |
. |
53506 |
0.16 |
chr1_8488032_8488525 | 0.30 |
RP5-1115A15.1 |
|
2580 |
0.27 |
chr6_52261106_52261257 | 0.30 |
EFHC1 |
EF-hand domain (C-terminal) containing 1 |
23925 |
0.19 |
chr11_95940247_95940453 | 0.30 |
ENSG00000266192 |
. |
134252 |
0.05 |
chr2_204398755_204399117 | 0.30 |
RAPH1 |
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
780 |
0.77 |
chr4_40216111_40216289 | 0.29 |
RHOH |
ras homolog family member H |
14236 |
0.21 |
chr8_125656871_125657085 | 0.29 |
RP11-532M24.1 |
|
65106 |
0.1 |
chr14_50406726_50407219 | 0.29 |
ENSG00000251929 |
. |
38304 |
0.11 |
chr1_89994823_89994991 | 0.29 |
LRRC8B |
leucine rich repeat containing 8 family, member B |
4445 |
0.28 |
chr12_55373549_55373788 | 0.29 |
TESPA1 |
thymocyte expressed, positive selection associated 1 |
1954 |
0.39 |
chr22_40644279_40644430 | 0.29 |
TNRC6B |
trinucleotide repeat containing 6B |
16653 |
0.23 |
chr7_138731189_138731354 | 0.29 |
ZC3HAV1L |
zinc finger CCCH-type, antiviral 1-like |
10496 |
0.21 |
chr10_63870514_63870665 | 0.29 |
ENSG00000221094 |
. |
5385 |
0.29 |
chr17_76709505_76709686 | 0.29 |
CYTH1 |
cytohesin 1 |
3512 |
0.24 |
chr7_33087595_33087805 | 0.29 |
ENSG00000241420 |
. |
1998 |
0.27 |
chr17_1773103_1773254 | 0.29 |
RPA1 |
replication protein A1, 70kDa |
9151 |
0.15 |
chr18_60979198_60979416 | 0.29 |
RP11-28F1.2 |
|
2008 |
0.3 |
chrX_40588576_40588727 | 0.29 |
MED14-AS1 |
MED14 antisense RNA 1 |
6001 |
0.23 |
chr7_144215265_144215416 | 0.29 |
ENSG00000221507 |
. |
66566 |
0.11 |
chr1_66741552_66741903 | 0.29 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
18397 |
0.28 |
chr2_197126192_197126464 | 0.29 |
AC020571.3 |
|
1171 |
0.51 |
chr18_43767825_43767976 | 0.29 |
C18orf25 |
chromosome 18 open reading frame 25 |
13900 |
0.21 |
chr8_117768274_117768425 | 0.29 |
EIF3H |
eukaryotic translation initiation factor 3, subunit H |
288 |
0.92 |
chr2_28809993_28810237 | 0.29 |
PLB1 |
phospholipase B1 |
14671 |
0.23 |
chr17_62505406_62505557 | 0.29 |
CEP95 |
centrosomal protein 95kDa |
880 |
0.41 |
chr5_153651606_153651926 | 0.29 |
ENSG00000221070 |
. |
67920 |
0.09 |
chr14_64116714_64117321 | 0.29 |
ENSG00000200693 |
. |
1200 |
0.38 |
chr1_167589694_167589845 | 0.29 |
RCSD1 |
RCSD domain containing 1 |
9561 |
0.19 |
chr15_90479619_90479888 | 0.29 |
C15orf38 |
chromosome 15 open reading frame 38 |
23565 |
0.1 |
chr9_95475297_95475448 | 0.29 |
IPPK |
inositol 1,3,4,5,6-pentakisphosphate 2-kinase |
42825 |
0.13 |
chr22_44722175_44722389 | 0.29 |
KIAA1644 |
KIAA1644 |
13551 |
0.24 |
chr3_49453158_49453470 | 0.29 |
TCTA |
T-cell leukemia translocation altered |
3675 |
0.11 |
chr5_150550351_150550502 | 0.28 |
ANXA6 |
annexin A6 |
12983 |
0.19 |
chr5_80304301_80304452 | 0.28 |
CTC-459I6.1 |
|
47650 |
0.15 |
chr5_154321009_154321226 | 0.28 |
MRPL22 |
mitochondrial ribosomal protein L22 |
455 |
0.8 |
chr12_90272899_90273318 | 0.28 |
ENSG00000252823 |
. |
125272 |
0.06 |
chr6_122721602_122721753 | 0.28 |
HSF2 |
heat shock transcription factor 2 |
981 |
0.66 |
chr14_75994181_75994458 | 0.28 |
BATF |
basic leucine zipper transcription factor, ATF-like |
5416 |
0.21 |
chr6_25032884_25033035 | 0.28 |
ENSG00000244618 |
. |
1449 |
0.4 |
chr5_118606969_118607129 | 0.28 |
TNFAIP8 |
tumor necrosis factor, alpha-induced protein 8 |
2600 |
0.27 |
chr16_22370083_22370234 | 0.28 |
RP11-21M24.3 |
|
6284 |
0.15 |
chr14_65164719_65164870 | 0.28 |
PLEKHG3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
6026 |
0.24 |
chr17_38022245_38022396 | 0.28 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
1879 |
0.24 |
chr2_128243399_128243684 | 0.28 |
ENSG00000202429 |
. |
13731 |
0.14 |
chr20_51596232_51596383 | 0.28 |
TSHZ2 |
teashirt zinc finger homeobox 2 |
7361 |
0.29 |
chr10_6588130_6588351 | 0.28 |
PRKCQ |
protein kinase C, theta |
33961 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.2 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.1 | 0.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.1 | 0.3 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.3 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.2 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.2 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.2 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.1 | 0.4 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.2 | GO:2000351 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 0.2 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.1 | 0.2 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.3 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.7 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.2 | GO:0042685 | negative regulation of heart induction by canonical Wnt signaling pathway(GO:0003136) negative regulation of cardioblast cell fate specification(GO:0009997) cardioblast cell fate commitment(GO:0042684) cardioblast cell fate specification(GO:0042685) regulation of cardioblast cell fate specification(GO:0042686) negative regulation of cardioblast differentiation(GO:0051892) cardiac cell fate specification(GO:0060912) negative regulation of heart induction(GO:1901320) negative regulation of cardiocyte differentiation(GO:1905208) regulation of cardiac cell fate specification(GO:2000043) negative regulation of cardiac cell fate specification(GO:2000044) |
0.1 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.2 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.1 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:0031935 | regulation of chromatin silencing(GO:0031935) negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.0 | 0.2 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.0 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.0 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.0 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.3 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.2 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.4 | GO:0043368 | positive T cell selection(GO:0043368) |
0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.0 | 0.1 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0001714 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 1.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.0 | GO:0002839 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.0 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.0 | 0.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0051665 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0021819 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.1 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0021894 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.0 | 0.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.0 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0016242 | regulation of macroautophagy(GO:0016241) negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.2 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.0 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.2 | GO:0072273 | metanephric nephron morphogenesis(GO:0072273) |
0.0 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.1 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.0 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.2 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.0 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0031442 | regulation of mRNA 3'-end processing(GO:0031440) positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.6 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.1 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.0 | GO:0070777 | D-amino acid transport(GO:0042940) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.4 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.1 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.0 | 0.0 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.2 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.0 | GO:0090009 | primitive streak formation(GO:0090009) |
0.0 | 0.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.2 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.0 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.0 | GO:0043247 | telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.3 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.2 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.1 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.0 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.2 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.1 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:1903310 | positive regulation of chromatin modification(GO:1903310) |
0.0 | 0.1 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.0 | 0.1 | GO:0098900 | regulation of action potential(GO:0098900) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.2 | GO:0051806 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.0 | 0.3 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 0.1 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.0 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.0 | 0.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.1 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0075713 | establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
0.0 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.0 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.0 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.1 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.6 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.0 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0050718 | positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.0 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.1 | GO:0009304 | tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.8 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.1 | GO:0098657 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:0010535 | regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.0 | 0.0 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.0 | 0.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.0 | 0.0 | GO:0021610 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) anatomical structure arrangement(GO:0048532) |
0.0 | 0.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.1 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.0 | GO:0042754 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.0 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.9 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.1 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.2 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.0 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.0 | GO:1903019 | negative regulation of glycoprotein biosynthetic process(GO:0010561) negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.0 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.0 | 0.0 | GO:0071801 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.1 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.0 | 0.0 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.0 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.0 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0072202 | cell differentiation involved in metanephros development(GO:0072202) |
0.0 | 0.0 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.0 | GO:0042596 | fear response(GO:0042596) |
0.0 | 0.1 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.2 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 1.1 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.4 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.4 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.2 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.2 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.5 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.0 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 1.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.0 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.3 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.0 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 1.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 1.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.0 | GO:0044216 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.5 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 1.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 1.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.0 | 0.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.1 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.6 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.6 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.0 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.0 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 1.2 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.0 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.0 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 1.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.0 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 2.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 1.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 1.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 1.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 1.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.4 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |